Survey: How Has Long Covid Impacted Your Life?

Help us keep you updated.​.

Please let us know more about you.

Help us keep you updated.

Please let us know more about you.

Help us keep you updated.​..

Please let us know more about you.

Washington D.C.

Cumulative Cost to Jan 31, 2022: $700M

% of Population with Long Covid: 5.6%

% of Population with Disabling Long Covid: 1.9%

# of Individuals with Long Covid: 38,000

# of Individuals with Disabling Long Covid: 13,000

Wyoming

Cumulative Cost to Jan 31, 2022: $775M

% of Population with Long Covid: 7.5%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 43,500

# of Individuals with Disabling Long Covid: 14,500

Wisconsin

Cumulative Cost to Jan 31, 2022: $8.1B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 450,000

# of Individuals with Disabling Long Covid: 150,000

West Virginia

Cumulative Cost to Jan 31, 2022: $2.3B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 132,000

# of Individuals with Disabling Long Covid: 44,000

Virginia

Cumulative Cost to Jan 31, 2022: $8.2B

% of Population with Long Covid: 5.4%

% of Population with Disabling Long Covid: 1.8%

# of Individuals with Long Covid: 457,000

# of Individuals with Disabling Long Covid: 151,000

Vermont

Cumulative Cost to Jan 31, 2022: $500M

% of Population with Long Covid: 4.5%

% of Population with Disabling Long Covid: 1.5%

# of Individuals with Long Covid: 28,000

# of Individuals with Disabling Long Covid: 9,000

Utah

Cumulative Cost to Jan 31, 2022: $4.7B

% of Population with Long Covid: 10%

% of Population with Disabling Long Covid: 4%

# of Individuals with Long Covid: 262,000

# of Individuals with Disabling Long Covid: 87,000

Texas

Cumulative Cost to Jan 31, 2022: $33B

% of Population with Long Covid: 6.6%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 1,840,000

# of Individuals with Disabling Long Covid: 611,000

Tennessee

Cumulative Cost to Jan 31, 2022: $9.9B

% of Population with Long Covid: 8.3%

% of Population with Disabling Long Covid: 2.8%

# of Individuals with Long Covid: 555,000

# of Individuals with Disabling Long Covid: 184,000

South Dakota

Cumulative Cost to Jan 31, 2022: $1.2B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 67,000

# of Individuals with Disabling Long Covid: 22,100

South Carolina

Cumulative Cost to Jan 31, 2022: $7.2B

% of Population with Long Covid: 8.3%

% of Population with Disabling Long Covid: 2.7%

# of Individuals with Long Covid: 410,000

# of Individuals with Disabling Long Covid: 136,000

Rhode Island

Cumulative Cost to Jan 31, 2022: $1.8B

% of Population with Long Covid: 9.5%

% of Population with Disabling Long Covid: 3.1%

# of Individuals with Long Covid: 100,000

# of Individuals with Disabling Long Covid: 33,000

Pennsylvania

Cumulative Cost to Jan 31, 2022: $14B

% of Population with Long Covid: 6.1%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 783,000

# of Individuals with Disabling Long Covid: 260,000

Oklahoma

Cumulative Cost to Jan 31, 2022: $5.1B

% of Population with Long Covid: 7.4%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 290,000

# of Individuals with Disabling Long Covid: 96,000

Ohio

Cumulative Cost to Jan 31, 2022: $14B

% of Population with Long Covid: 6.6%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 763,000

# of Individuals with Disabling Long Covid: 253,000

North Dakota

Cumulative Cost to Jan 31, 2022: $1.2B

% of Population with Long Covid: 8.8%

% of Population with Disabling Long Covid: 2.9%

# of Individuals with Long Covid: 66,500

# of Individuals with Disabling Long Covid: 22,000

North Carolina

Cumulative Cost to Jan 31, 2022: $12.6B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 716,000

# of Individuals with Disabling Long Covid: 238,000

New York

Cumulative Cost to Jan 31, 2022: $17.5B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 1,400,000

# of Individuals with Disabling Long Covid: 464,000

New Mexico

Cumulative Cost to Jan 31, 2022: $2.5B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 142,000

# of Individuals with Disabling Long Covid: 47,000

New Jersey

Cumulative Cost to Jan 31, 2022: $11B

% of Population with Long Covid: 7%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 619,000

# of Individuals with Disabling Long Covid: 205,000

New Hampshire

Cumulative Cost to Jan 31, 2022: $1.5B

% of Population with Long Covid: 6.1%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 81,500

# of Individuals with Disabling Long Covid: 27,000

Nevada

Cumulative Cost to Jan 31, 2022: $3.5B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 195,000

# of Individuals with Disabling Long Covid: 65,000

Nebraska

Cumulative Cost to Jan 31, 2022: $2.4B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 131,000

# of Individuals with Disabling Long Covid: 43,500

Montana

Cumulative Cost to Jan 31, 2022: $1.3B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 72,000

# of Individuals with Disabling Long Covid: 24,000

Missouri

Cumulative Cost to Jan 31, 2022: $7.1B

% of Population with Long Covid: 6.5%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 394,000

# of Individuals with Disabling Long Covid: 131,000

Mississippi

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 216,000

# of Individuals with Disabling Long Covid: 72,000

Minnesota

Cumulative Cost to Jan 31, 2022: $7B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 391,000

# of Individuals with Disabling Long Covid: 130,000

Michigan

Cumulative Cost to Jan 31, 2022: $12B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 669,000

# of Individuals with Disabling Long Covid: 222,000

Massachusetts

Cumulative Cost to Jan 31, 2022: $8.6B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 472,000

# of Individuals with Disabling Long Covid: 156,000

Maryland

Cumulative Cost to Jan 31, 2022: $5.2B

% of Population with Long Covid: 4.7%

% of Population with Disabling Long Covid: 1.6%

# of Individuals with Long Covid: 281,000

# of Individuals with Disabling Long Covid: 93,000

Maine

Cumulative Cost to Jan 31, 2022: $940M

% of Population with Long Covid: 3.9%

% of Population with Disabling Long Covid: 1.3%

# of Individuals with Long Covid: 52,000

# of Individuals with Disabling Long Covid: 17,000

Louisiana

Cumulative Cost to Jan 31, 2022: $5.9B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 330,000

# of Individuals with Disabling Long Covid: 110,000

Kentucky

Cumulative Cost to Jan 31, 2022: $6.1B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 344,000

# of Individuals with Disabling Long Covid: 114,000

Kansas

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 7.4%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 216,000

# of Individuals with Disabling Long Covid: 72,000

Iowa

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 214,000

# of Individuals with Disabling Long Covid: 71,000

Indiana

Cumulative Cost to Jan 31, 2022: $8.7B

% of Population with Long Covid: 7.3%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 481,100

# of Individuals with Disabling Long Covid: 160,000

Illinois

Cumulative Cost to Jan 31, 2022: $16B

% of Population with Long Covid: 10%

% of Population with Disabling Long Covid: 4%

# of Individuals with Long Covid: 860,000

# of Individuals with Disabling Long Covid: 285,000

Idaho

Cumulative Cost to Jan 31, 2022: $2B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 113,000

# of Individuals with Disabling Long Covid: 37,500

Hawaii

Cumulative Cost to Jan 31, 2022: $1.1B

% of Population with Long Covid: 4.4%

% of Population with Disabling Long Covid: 1.4%

# of Individuals with Long Covid: 62,000

# of Individuals with Disabling Long Covid: 20,500

Georgia

Cumulative Cost to Jan 31, 2022: $12.6B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 702,000

# of Individuals with Disabling Long Covid: 233,000

Florida

Cumulative Cost to Jan 31, 2022: $30B

% of Population with Long Covid: 7.9%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 1,640,000

# of Individuals with Disabling Long Covid: 544,000

Delaware

Cumulative Cost to Jan 31, 2022: $1.3B

% of Population with Long Covid: 7.7%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 73,000

# of Individuals with Disabling Long Covid: 24,000

Connecticut

Cumulative Cost to Jan 31, 2022: $3.7B

% of Population with Long Covid: 5.7%

% of Population with Disabling Long Covid: 1.9%

# of Individuals with Long Covid: 205,000

# of Individuals with Disabling Long Covid: 68,000

Colorado

Cumulative Cost to Jan 31, 2022: $6.7B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 370,00

# of Individuals with Disabling Long Covid: 123,000

California

Cumulative Cost to Jan 31, 2022: $43B

% of Population with Long Covid: 6.3%

% of Population with Disabling Long Covid: 2.1%

# of Individuals with Long Covid: 2,470,000

# of Individuals with Disabling Long Covid: 817,000

Arkansas

Cumulative Cost to Jan 31, 2022: $4.1B

% of Population with Long Covid: 7.7%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 230,000

# of Individuals with Disabling Long Covid: 76,500

Arizona

Cumulative Cost to Jan 31, 2022: $9.8B

% of Population with Long Covid: 8%

% of Population with Disabling Long Covid: 2.7%

# of Individuals with Long Covid: 554,000

# of Individuals with Disabling Long Covid: 184,000

Alaska

Cumulative Cost to Jan 31, 2022: $1B

% of Population with Long Covid: 8.4%

% of Population with Disabling Long Covid: 2.8%

# of Individuals with Long Covid: 62,000

# of Individuals with Disabling Long Covid: 21,000

Oregon

Cumulative Cost to Jan 31, 2022: $3.3B

% of Population with Long Covid: 4.6%

% of Population with Disabling Long Covid: 1.5%

# of Individuals with Long Covid: 187,000

# of Individuals with Disabling Long Covid: 62,000

Alabama

Cumulative Cost to Jan 31, 2022: $6.5B

% of Population with Long Covid: 7.5%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 363,000

# of Individuals with Disabling Long Covid: 121,000

Washington

Cumulative Cost to Jan 31, 2022: $6.7B

% of Population with Long Covid: 5.4%

% of Population with Disabling Long Covid: 1.8%

# of Individuals with Long Covid: 394,000

# of Individuals with Disabling Long Covid: 130,000